Item
2.02 Results
of Operations and Financial Condition.
On
December 13, 2007, Aeolus Pharmaceuticals, Inc. issued an earnings release
to
announce its earnings for the three months and twelve months ended September
30,
2007.
The
earnings release is included in this report as Exhibit 99.1.
The
information in Exhibit 99.1 is being furnished and shall not be deemed “filed”
for the purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that Section. The
information in Exhibit 99.1 shall not be deemed incorporated by reference into
any registration statement or other document filed with the Securities and
Exchange Commission (the “SEC”), regardless of any general incorporation
language in such filing.
Item
9.01. Financial Statements and Exhibits.
|
(c)
|
Exhibits
|
|
Exhibit
#
|
Description
|
|
|
99.1
|
Press
release dated December 13, 2007
|
SIGNATURE
Pursuant
to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report
to
be signed on its behalf by the undersigned hereunto duly
authorized.
AEOLUS
PHARMACEUTICALS,
INC.
Date: December
13, 2007
/s/
Michael P.
McManus___________________
Michael
P. McManus
Chief
Financial Officer, Treasurer and Secretary